➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: December 5, 2020

DrugPatentWatch Database Preview

Patent: 10,273,252

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,273,252
Title:Substituted dihydropyrrolopyrazole derivative
Abstract: The present invention provides a compound represented by the general formula (Ia) or a pharmacologically acceptable salt thereof. In the general formula (Ia), two R moieties each independently represent a C.sub.1-3 alkyl group or the like; and R.sup.1, R.sup.2 and R.sup.3 each independently represent an optionally substituted linear or branched C.sub.1-4 alkyl group. ##STR00001##
Inventor(s): Iwase; Noriaki (Ube, JP), Aga; Yasuhiro (Ube, JP), Ushiyama; Shigeru (Ube, JP), Kono; Shigeyuki (Ube, JP), Sunamoto; Hidetoshi (Ube, JP), Matsushita; Takashi (Ube, JP), Ogi; Sayaka (Ube, JP), Umezaki; Satoshi (Ube, JP), Kojima; Masahiro (Ube, JP), Onuma; Kazuhiro (Ube, JP), Shiraishi; Yusuke (Ube, JP), Okudo; Makoto (Ube, JP), Kimura; Tomio (Tokyo, JP)
Assignee: UBE INDUSTRIES, LTD. (Yamaguchi, JP)
Application Number:15/736,677
Patent Claims:see list of patent claims

Details for Patent 10,273,252

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Glaxosmithkline NUCALA mepolizumab INJECTABLE;SUBCUTANEOUS 761122 001 2019-06-06   Start Trial UBE INDUSTRIES, LTD. (Yamaguchi, JP) 2036-04-28 RX search
Genentech Inc HERCEPTIN HYLECTA trastuzumab; hyaluronidase-oysk INJECTABLE;SUBCUTANEOUS 761106 001 2019-02-28   Start Trial UBE INDUSTRIES, LTD. (Yamaguchi, JP) 2036-04-28 RX search
Emd Serono Inc BAVENCIO avelumab INJECTABLE;INTRAVENOUS 761078 001 2017-05-09   Start Trial UBE INDUSTRIES, LTD. (Yamaguchi, JP) 2036-04-28 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.